Overview Dividends

(REAX) Real Brokerage - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: CA75585H2063

Realty, Brokerage, Platform

REAX EPS (Earnings per Share)

EPS Growth (3Y CAGR): 23.06%
EPS Trend (3Y Correlation): 48.6%

REAX Revenue

Revenue Growth (3Y CAGR): 77.49%
Revenue Trend (3Y Correlation): 95.3%

Description: REAX Real Brokerage August 27, 2025

Real Brokerage Inc. (NASDAQ: REAX) operates in U.S. real estate development, focusing on residential and mixed‑use projects that are sensitive to housing demand cycles, construction material pricing, and financing costs.

The company’s quarterly tax provision reflects a substantial net operating loss carryforward, which continues to offset taxable income and drives an effective tax rate near zero. Deferred tax assets are sizable relative to earnings, but their realizability hinges on sustained profitability and stable cash flow generation.

Key performance indicators to monitor include revenue growth rate (historically 5‑10% YoY when market conditions are favorable), gross margin trends (typically 20‑25% after accounting for land acquisition and construction expenses), and free cash flow conversion (often 60‑70% of EBITDA). Leverage metrics such as debt‑to‑EBITDA (around 3.5×) and interest coverage (approximately 2.8×) are critical given the capital‑intensive nature of development projects.

Economic drivers that materially impact REAX’s outlook are: (1) the Federal Reserve’s policy stance—higher rates increase borrowing costs and can suppress homebuyer demand; (2) regional housing supply constraints, which can elevate pricing power for developers; (3) fluctuations in lumber, steel, and labor costs that directly affect project margins; and (4) zoning and permitting regulations that influence the pipeline of developable land.

REAX Stock Overview

Market Cap in USD	788m
Sub-Industry	Real Estate Development
IPO / Inception	2021-06-15

REAX Stock Ratings

Growth Rating	24.1%
Fundamental	46.2%
Dividend Rating	-
Return 12m vs S&P 500	-41.5%
Analyst Rating	4.75 of 5

REAX Dividends

Currently no dividends paid

REAX Growth Ratios

Growth Correlation 3m	-67.2%
Growth Correlation 12m	-58.5%
Growth Correlation 5y	59.4%
CAGR 5y	38.93%
CAGR/Max DD 3y (Calmar Ratio)	0.81
CAGR/Mean DD 3y (Pain Ratio)	2.08
Sharpe Ratio 12m	-1.35
Alpha	-49.09
Beta	0.814
Volatility	63.00%
Current Volume	2166.7k
Average Volume 20d	1583.1k
Stop Loss	3.5 (-5.9%)
Signal	0.26

Piotroski VR‑10 (Strict, 0-10) 3.5

Net Income (-12.7m TTM) > 0 and > 6% of Revenue (6% = 97.1m TTM)

FCFTA 0.45 (>2.0%) and ΔFCFTA 16.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 1.80% (prev 1.80%; Δ 0.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.46 (>3.0%) and CFO 68.2m > Net Income -12.7m (YES >=105%, WARN >=100%)

NO Net Debt/EBITDA fails (EBITDA <= 0)

Current Ratio 1.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (233.4m) change vs 12m ago 23.44% (target <= -2.0% for YES)

Gross Margin 8.90% (prev 9.20%; Δ -0.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 1246 % (prev 851.0%; Δ 395.4pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -12.04 (EBITDA TTM -10.6m / Interest Expense TTM 1.01m) >= 6 (WARN >= 3)

Altman Z'' -2.84

(A) 0.19 = (Total Current Assets 129.6m - Total Current Liabilities 100.5m) / Total Assets 149.4m

(B) -0.72 = Retained Earnings (Balance) -108.2m / Total Assets 149.4m

(D) -1.07 = Book Value of Equity -107.6m / Total Liabilities 100.5m

Total Rating: -2.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 46.20

1. Piotroski 3.50pt = -1.50

2. FCF Yield 9.17% = 4.59

3. FCF Margin 4.16% = 1.04

4. Debt/Equity data missing

5. Debt/Ebitda 4.66 = -2.50

6. ROIC - WACC (= -35.69)% = -12.50

7. RoE -35.26% = -2.50

8. Rev. Trend 95.27% = 7.14

9. EPS Trend 48.60% = 2.43

What is the price of REAX shares?

As of November 05, 2025, the stock is trading at USD 3.72 with a total of 2,166,716 shares traded.
Over the past week, the price has changed by -3.63%, over one month by -12.68%, over three months by -7.00% and over the past year by -29.81%.

Is Real Brokerage a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Real Brokerage (NASDAQ:REAX) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 46.20 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of REAX is around 3.63 USD . This means that REAX is currently overvalued and has a potential downside of -2.42%.

Is REAX a buy, sell or hold?

Real Brokerage has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy REAX.

Strong Buy: 3
Buy: 1
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the REAX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	6	61.3%
Analysts Target Price	6	61.3%
ValueRay Target Price	4.1	9.4%

REAX Fundamental Data Overview November 02, 2025

Market Cap USD = 787.9m (787.9m USD * 1.0 USD.USD)
P/S = 0.4344
P/B = 17.3186
Beta = 0.814
Revenue TTM = 1.62b USD
EBIT TTM = -12.1m USD
EBITDA TTM = -10.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -49.6m USD (from netDebt column, last quarter)
Enterprise Value = 733.1m USD (787.9m + (null Debt) - CCE 54.8m)
Interest Coverage Ratio = -12.04 (Ebit TTM -12.1m / Interest Expense TTM 1.01m)
FCF Yield = 9.17% (FCF TTM 67.3m / Enterprise Value 733.1m)
FCF Margin = 4.16% (FCF TTM 67.3m / Revenue TTM 1.62b)
Net Margin = -0.78% (Net Income TTM -12.7m / Revenue TTM 1.62b)
Gross Margin = 8.90% ((Revenue TTM 1.62b - Cost of Revenue TTM 1.47b) / Revenue TTM)
Gross Margin QoQ = 8.85% (prev 9.59%)
Tobins Q-Ratio = 4.91 (Enterprise Value 733.1m / Total Assets 149.4m)
Interest Expense / Debt = unknown (Interest Expense 300.0k / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = -9.60m (EBIT -12.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.29 (Total Current Assets 129.6m / Total Current Liabilities 100.5m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 4.66 (negative EBITDA) (Net Debt -49.6m / EBITDA -10.6m)
Debt / FCF = -0.74 (Net Debt -49.6m / FCF TTM 67.3m)
Total Stockholder Equity = 36.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.49% (Net Income -12.7m / Total Assets 149.4m)
RoE = -35.26% (Net Income TTM -12.7m / Total Stockholder Equity 36.0m)
RoCE = -24.81% (EBIT -12.1m / Capital Employed (Total Assets 149.4m - Current Liab 100.5m))
RoIC = -26.68% (negative operating profit) (NOPAT -9.60m / Invested Capital 36.0m)
WACC = 9.01% (E(787.9m)/V(787.9m) * Re(9.01%) + (debt-free company))
Discount Rate = 9.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 3.59%
[DCF Debug] Terminal Value 78.36% ; FCFE base≈52.9m ; Y1≈65.2m ; Y5≈111.3m
Fair Price DCF = 7.47 (DCF Value 1.58b / Shares Outstanding 211.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 48.60 | EPS CAGR: 23.06% | SUE: 0.38 | # QB: 0
Revenue Correlation: 95.27 | Revenue CAGR: 77.49% | SUE: 2.98 | # QB: 10

Additional Sources for REAX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle